Gene Query: SLC16A14

Dataset Description Geneva Score
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 89.0
Nutritional control of protein translation 68.24
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 55.75
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 46.14
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 40.28
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 37.31
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 21.96
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 20.17
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 19.32
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 18.44
Comparing gene expression in iPSC derived RPE from control and AMD donors 17.17
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 16.27
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 16.22
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 16.07
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 16.07
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 15.62
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 15.48
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 15.0
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 14.57
Examining serotonergic neuron differentiation from human iPSCs 14.48
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 13.47
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 13.47
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 13.47
HNRNPL and its RNA Targets in Prostate Cancer 12.25
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 12.25
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 12.17
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 12.01
Expression charcaterization of an internal protocol developed to differentiate RPE cells 11.78
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 11.6
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 11.33
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 11.26
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  11.1
MRTF activates TEAD-YAP target gene expression 10.96
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 10.91
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 10.89
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 10.73
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 10.62
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 10.21
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 9.28
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 9.21
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 9.21
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 9.2
IRF1 regulates IFN dependent and independent gene expression 9.16
RNA expression following TMPRSS11B overexpression or depletion 9.09
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 9.06
LNCaP treated with iBET 9.03
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 8.65
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 8.57
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 8.54
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 8.52
Persistence of stem cell metabolism in cancers as a failure of differentiation 8.46
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 8.27
Differential Gene Expression between MCF10A and MCF7 cells 7.94
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 7.6
The effect of Abl kinases on non-small cell carcinoma global transcriptome 7.55
The effect of insulin on mRNA transcription of human pluripotent stem cells 7.4
RNA-seq of MCF10A cells and CAF 7.33
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 7.3
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 7.29
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 7.18
Androgen Receptor-regulated genes in prostate cancer cells 7.18
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 7.18
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 7.14
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 6.95
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 6.86
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 6.82
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 6.7
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 6.67
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 6.65
Co-regulation of splicing by Rbfox1 and hnRNP M 6.65
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 6.49
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 6.49
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 6.36
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 6.35
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 6.33
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 6.2
Maturation of human iNSCs 6.17
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 6.09
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 6.05
IL-33 activates tumor stroma to promote intestinal polyposis 5.92
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 5.88
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 5.77
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 5.77
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 5.7
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 5.63
RNA-seq in transgenic cells 5.57
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 5.4
Global transcriptome analysis of HAP1 cells 5.3
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 5.26
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 5.22
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 5.21
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 5.2
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 5.18
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 5.17
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 5.11
Human HAP1 cells before and after nutrient deprivation 5.11
Global analysis of alternative splicing regulated by RBM10 4.93
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 4.92
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 4.9
HNRNPM-regulated splicing dependencies in prostate cancer 4.9
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  4.87
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 4.82
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 4.82
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 4.82
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 4.77
Cajal bodies are linked to genome conformation [RNA-Seq] 4.74
Cajal bodies are linked to genome conformation 4.74
Genome-wide transcriptional response to random aneuploidy in human cells 4.65
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 4.63
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 4.59
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 4.59
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 4.56
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 4.55
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 4.53
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 4.49
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 4.47
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 4.45
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 4.44
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 4.41
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 4.37
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 4.37
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 4.36
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 4.32
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 4.26
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 4.18
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 4.1
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 4.03
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 4.01
LINE-2 transposable elements are a source of functional human microRNAs and target sites 4.01
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 3.93
The role of FAM46C in myeloma cells 3.88
The role of FAM46C in myeloma cells [sequencing] 3.88
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 3.83
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 3.82
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 3.78
Non-coding regions are the main source of tumor-specific antigens 3.73
Non-coding regions are the main source of tumor-specific antigens [human] 3.73
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 3.72
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 3.71
JAK dependent survival of ALK- ALCL 3.7
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 3.63
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 3.56
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 3.54
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 3.54
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 3.51
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 3.49
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 3.49
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 3.46
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 3.46
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 3.45
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 3.45
Selective expression of long non-coding RNAs in a breast cancer cell progression model 3.44
Effect of CHKA knockdown on C4-2 cell transcriptome 3.31
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 3.3
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 3.29
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 3.26
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 3.15
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 3.14
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 3.12
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 3.12
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 3.1
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 3.1
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 3.1
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 3.04
Ribosomal protein RPL26 is the principal target of UFMylation 3.02
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 3.02
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 3.02
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 2.96
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 2.93
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 2.91
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 2.91
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 2.88
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 2.79
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 2.78
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 2.78
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 2.77
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 2.77
A map of gene expression in neutrophil-like cell lines 2.77
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 2.77
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 2.76
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 2.76
HEK293 TFAM Knockout Expression Study 2.75
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 2.74
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 2.71
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 2.69
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 2.68
R430: A potent inbibitor of DNA and RNA viruses 2.65
Overexpression of NFIB and YBX1 in MCF-7 cells 2.65
PTHrP overexpression in MCF7 cells 2.63
RNA-seq analysis of breast cancer 2.62
RNA-seq analysis and shRNA screen of breast cancer 2.62
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 2.6
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 2.6
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 2.59
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 2.54
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 2.53
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 2.5
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 2.5
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 2.5
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 2.47
Identification of HOXB13 target genes responsive to BET inhibitors 2.44
Overexpression and knockdown experiment for circCSNK1G3 2.4
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 2.36
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 2.36
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 2.35
Activity-dependent transcriptional changes in human neurons 2.35
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 2.34
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 2.34
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 2.32
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 2.31
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 2.3
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 2.3
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 2.29
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 2.29
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 2.25
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 2.24
Transcriptome analysis of H9 hESC derived cerebral organoids 2.23
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 2.22
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 2.21
CDK4/6 inhibitor resistance in prostate cancer 2.2
FGF2 regulation of gene expression in stable inducible Neurons 2.18
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 2.18
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 2.18
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 2.15
Paxillin regulates genomic networks in prostate cancer [C4-2] 2.15
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 2.12
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 2.11
Gene expression analysis upon mtDNA depletion [RNA-seq] 2.11
Gene expression analysis upon mtDNA depletion 2.11
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 2.1
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 2.09
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 2.09
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 2.09
LIN28A modulates splicing and gene expression programs in breast cancer cells 2.09
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 2.09
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 2.08
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 2.07
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 2.06
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 2.03
iPSC-Derived Cholangiocytes 2.01
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 2.01
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 2.01
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 1.99
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 1.98
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 1.93
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 1.92
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 1.91
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 1.9
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 1.89
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 1.88
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 1.87
Differential Protein Occupancy Profiling of the mRNA Transcriptome 1.86
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 1.86
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.85
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 1.85
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 1.85
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 1.85
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 1.84
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 1.84
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 1.84
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 1.83
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 1.82
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 1.82
The cohesin release factor WAPL restricts chromatin loop extension. 1.82
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 1.81
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 1.81
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 1.8
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 1.8
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 1.79
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 1.79
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 1.78
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 1.77
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.77
DJ-1 is dispensable for human stem cell homeostasis 1.77
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 1.76
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 1.75
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 1.73
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 1.72
Regulation of protein translation during mitosis 1.71
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 1.7
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 1.68
Hypoxic transcriptome of SQ20B human head and neck cancer cells 1.68
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 1.67
RNA-seq analysis of RALD iPSCs after in vitro differentiation 1.66
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 1.66
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 1.65
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 1.65
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 1.65
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 1.65
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 1.65
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 1.65
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 1.65
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 1.65
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 1.65
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 1.62
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 1.62
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 1.59
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 1.59
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 1.59
Effect of FGF13 depletion on the H460 cell line 1.59
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 1.58
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 1.57
Expression profiling of MCF-7 cells with treatment of TCDD 1.57
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 1.57
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 1.56
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 1.56
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 1.55
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 1.55
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 1.55
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 1.55
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 1.54
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 1.53
Patient-derived luminal breast cancer xenografts with progestins 1.53
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 1.53
Expression profiles of the four human major ectodermal lineages 1.53
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 1.53
RNA-Seq of the corpus callosum from 12 individuals 1.53
Functional role of SLIT2 and ROBO1 in trophoblasts 1.53
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 1.52
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 1.52
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 1.49
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 1.48
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 1.48
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 1.48
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 1.47
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 1.47
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 1.46
Targeted enhancer activation by a subunit of the integrator complex 1.45
A prostate cancer chromatin interaction map 1.44
CHCHD2 gene KO effect in iPSC drived motor neurons 1.43
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 1.43
PRDM1 inhibits proliferation of human colon cancer organoids 1.42
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 1.41
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 1.4
Downregulation of LATS kinases alters p53 to promote cell migration 1.4
RNAseq analysis of ESRP regulated splicing events in prostate cancer 1.4
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 1.4
RNA-Seq in PWS iPSC-derived neurons 1.38
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 1.37
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.36
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 1.36
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 1.35
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 1.35
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 1.34
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 1.31
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 1.31
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 1.31
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 1.31
Transcriptome profiling of Normal and Cancerous Prostate Cells 1.31
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 1.3
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 1.29
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 1.28
BI Human Reference Epigenome Mapping Project 1.28
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 1.28
Identification of global XBP1s target gene expression in human prostate cancer cells 1.28
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 1.26
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 1.26
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 1.24
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 1.23
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 1.22
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 1.22
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 1.22
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 1.22
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 1.2
Conservative alteration of chromosomal expression pattern across human solid tumor types 1.2
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 1.19
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 1.18
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 1.17
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 1.16
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 1.15
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 1.15
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 1.15
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 1.15
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 1.15
Role for citron kinase in prostate cancer growth 1.1
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 1.08
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 1.08
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 1.08
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 1.08
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 1.07
Fusion discovery in breast cancer cell line 1.05
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 1.04
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 1.04
Effects of transcription on genome - nuclear lamina interactions 1.04
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 1.01
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 1.01
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 1.01
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 1.0
PNET animal model: new insights (II) 0.99
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 0.98
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 0.97
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 0.94
CHCHD10 gene KO effect in iPSC drived motor neurons 0.94
The MEF2B Regulatory Network - RNA-seq data 0.9
The MEF2B Regulatory Network 0.9
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 0.88
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 0.84
Developmental stage specific chromosome architecture in human erythroid cells 0.82
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 0.82
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 0.8
Effect of nuclear IL-33 on gene expression 0.8
Gene expression profile of multiple myeloma cell lines treated with CB-5083 0.79
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 0.78
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.76
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 0.75
iPSC derived motor neuron cultures from C9ORF72 carriers 0.74
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 0.72
Efficient derivation of microglia-like cells from human pluripotent stem cells 0.72
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.71
Functional astrocytes differentiated from hiPSCs 0.69
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.68
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.68
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 0.66
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 0.66
RNAseq in Alzheimer's Disease patients 0.65
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 0.64
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 0.64
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 0.64
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 0.64
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.62
SNHG5 siRNA knock down in HCT116 cells 0.62
RNAseq of Breast cancer PDX samples 0.58
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 0.57
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 0.57
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.56
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 0.54
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.54
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.5
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 0.49
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 0.48
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 0.48
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 0.48
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.48
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 0.47
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 0.46
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.45
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.45
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.44
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 0.42
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 0.42
Single-cell analysis of adult human ovary using 10X genomics 0.42
Engineering Patient-Specific Tissue Implants 0.42
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.41
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.39
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.39
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 0.38
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 0.38
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 0.38
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 0.38
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 0.37
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 0.36
RNA sequencing of matched nephrectomy samples [RNA-seq] 0.36
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 0.35
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 0.35
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 0.34
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 0.34
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 0.33
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 0.33
Identification of long noncoding RNAs regulated by p53 0.32
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 0.32
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.32
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.32
RNA seq_PDX2_SHP099 0.31
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 0.3
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.3
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.3
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.28
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 0.28
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 0.27
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.26
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.25
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.24
RNAseq of cell lines with knocked in ESR1 mutations 0.24
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 0.23
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 0.23
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.23
The transcriptome and chromatin accessbility landscape of mammalian germline 0.18
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.17
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.16
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.16
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 0.15
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.15
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 0.14
MCF-7 as a model for functional analysis of breast cancer risk variants 0.13
Subtle asymmetry of gene expression in embryonic and foetal human brains 0.13
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 0.12
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 0.11
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 0.11
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 0.1
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 0.09
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 0.09
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.08
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 0.08
Measure transcript integrity using RNA-seq data 0.07
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 0.05
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.05
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 0.03
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 0.02
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.02
Zika virus directly infects human peripheral neurons and induces cell death 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation